Literature DB >> 32713734

Predicting Acute Kidney Injury After Cardiac Surgery Using a Simpler Model.

Tim Coulson1, Michael Bailey2, Dave Pilcher3, Christopher M Reid4, Siven Seevanayagam5, Jenni Williams-Spence6, Rinaldo Bellomo7.   

Abstract

OBJECTIVE: To develop a simple model for the prediction of acute kidney injury (AKI) and renal replacement therapy (RRT) that could be used in clinical or research risk stratification.
DESIGN: Retrospective analysis.
SETTING: Multi-institutional. PARTICIPANTS: All cardiac surgery patients from September 2016 to December 2018.
INTERVENTIONS: Observational.
MEASUREMENTS AND MAIN RESULTS: The study cohort was divided into a development set (75%) and validation set (25%). The following 2 data epochs were used: preoperative data and immediate postoperative data (within 4 h of intensive care unit admission). Univariate statistics were used to identify variables associated with AKI or RRT. Stepwise logistic regression was used to develop a parsimonious model. Model discrimination and calibration were evaluated in the test set. Models were compared with previously published models and with a more comprehensive model developed using the least absolute shrinkage and selection operator. The study included 22,731 patients at 33 hospitals. The incidences of AKI (any stage) and RRT for the present analysis were 5,829 patients (25.6%) and 488 patients (2.1%), respectively. Models were developed for AKI, with an area under the receiver operating curve (AU-ROC) of 0.67 and 0.69 preoperatively and postoperatively, respectively. Models for RRT had an AU-ROC of 0.77 and 0.80 preoperatively and postoperatively, respectively. These models contained between 3 and 5 variables. Comparatively, comprehensive least absolute shrinkage and selection operator models contained between 21 and 26 variables, with an AU-ROC of 0.71 and 0.72 for AKI and 0.84 and 0.87 for RRT respectively.
CONCLUSION: In the present study, simple, clinically applicable models for predicting AKI and RRT preoperatively and immediate postoperatively were developed. Even though AKI prediction remained poor, RRT prediction was good with a parsimonious model.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; cardiac surgery; renal replacement therapy; risk prediction

Mesh:

Year:  2020        PMID: 32713734     DOI: 10.1053/j.jvca.2020.06.072

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  5 in total

1.  Development and Validation of a Personalized Model With Transfer Learning for Acute Kidney Injury Risk Estimation Using Electronic Health Records.

Authors:  Kang Liu; Xiangzhou Zhang; Weiqi Chen; Alan S L Yu; John A Kellum; Michael E Matheny; Steven Q Simpson; Yong Hu; Mei Liu
Journal:  JAMA Netw Open       Date:  2022-07-01

2.  A LASSO-derived clinical score to predict severe acute kidney injury in the cardiac surgery recovery unit: a large retrospective cohort study using the MIMIC database.

Authors:  Tucheng Huang; Wanbing He; Yong Xie; Wenyu Lv; Yuewei Li; Hongwei Li; Jingjing Huang; Jieping Huang; Yangxin Chen; Qi Guo; Jingfeng Wang
Journal:  BMJ Open       Date:  2022-06-02       Impact factor: 3.006

3.  Aortic Risks Prediction Models after Cardiac Surgeries Using Integrated Data.

Authors:  Iuliia Lenivtceva; Dmitri Panfilov; Georgy Kopanitsa; Boris Kozlov
Journal:  J Pers Med       Date:  2022-04-15

Review 4.  Diagnosis of Cardiac Surgery-Associated Acute Kidney Injury: State of the Art and Perspectives.

Authors:  Alfredo G Casanova; Sandra M Sancho-Martínez; Laura Vicente-Vicente; Patricia Ruiz Bueno; Pablo Jorge-Monjas; Eduardo Tamayo; Ana I Morales; Francisco J López-Hernández
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

5.  A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery.

Authors:  T G Coulson; L F Miles; A Serpa Neto; D Pilcher; L Weinberg; G Landoni; A Zarbock; R Bellomo
Journal:  Anaesthesia       Date:  2022-09       Impact factor: 12.893

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.